Bafna Pharmaceuticals Limited (BAFNAPH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.102x

Based on the latest financial reports, Bafna Pharmaceuticals Limited (BAFNAPH) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs93.12 Million ≈ $1.01 Million USD) by net assets (Rs912.28 Million ≈ $9.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bafna Pharmaceuticals Limited (BAFNAPH) total market value for the company's overall valuation and market capitalisation.

Bafna Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Bafna Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bafna Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bafna Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore BAFNAPH cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Western Energy Services Corp. TO:WRG	0.027x
AimCore Technology Co Ltd TWO:3615	0.041x
Edisun Power Europe AG SW:ESUN	-0.041x
Baikowski SASU PA:ALBKK	0.027x
Lifevantage Corporation NASDAQ:LFVN	0.142x
Investec plc LSE:INVR	0.009x
Prime Electronics & Satellitics Inc TW:6152	-0.095x
ZOOZ Power Ltd. Ordinary Shares NASDAQ:ZOOZ	72.087x

Annual Cash Flow Conversion Efficiency for Bafna Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Bafna Pharmaceuticals Limited from 2005 to 2026. View BAFNAPH stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs1.00 Billion ≈ $10.83 Million	Rs118.27 Million ≈ $1.28 Million	0.118x	-48.72%
2025-03-31	Rs848.07 Million ≈ $9.17 Million	Rs195.29 Million ≈ $2.11 Million	0.230x	+96.27%
2024-03-31	Rs808.39 Million ≈ $8.74 Million	Rs94.85 Million ≈ $1.03 Million	0.117x	+74.02%
2023-03-31	Rs734.55 Million ≈ $7.94 Million	Rs49.52 Million ≈ $535.59K	0.067x	-57.06%
2022-03-31	Rs619.64 Million ≈ $6.70 Million	Rs97.28 Million ≈ $1.05 Million	0.157x	+165.49%
2021-03-31	Rs567.71 Million ≈ $6.14 Million	Rs-136.09 Million ≈ $-1.47 Million	-0.240x	+64.19%
2020-03-31	Rs511.95 Million ≈ $5.54 Million	Rs-342.68 Million ≈ $-3.71 Million	-0.669x	-606.06%
2019-03-31	Rs188.52 Million ≈ $2.04 Million	Rs-17.87 Million ≈ $-193.28K	-0.095x	+49.95%
2018-03-31	Rs372.02 Million ≈ $4.02 Million	Rs-70.47 Million ≈ $-762.14K	-0.189x	-742.20%
2017-03-31	Rs421.12 Million ≈ $4.55 Million	Rs-9.47 Million ≈ $-102.44K	-0.022x	-242.15%
2016-03-31	Rs575.71 Million ≈ $6.23 Million	Rs9.11 Million ≈ $98.52K	0.016x	-89.21%
2015-03-31	Rs727.13 Million ≈ $7.86 Million	Rs106.65 Million ≈ $1.15 Million	0.147x	+536.93%
2014-03-31	Rs697.48 Million ≈ $7.54 Million	Rs16.06 Million ≈ $173.70K	0.023x	-95.71%
2013-03-31	Rs683.04 Million ≈ $7.39 Million	Rs366.32 Million ≈ $3.96 Million	0.536x	+460.94%
2012-03-31	Rs646.17 Million ≈ $6.99 Million	Rs-96.01 Million ≈ $-1.04 Million	-0.149x	-26.74%
2011-03-31	Rs541.89 Million ≈ $5.86 Million	Rs-63.53 Million ≈ $-687.07K	-0.117x	-708.49%
2010-03-31	Rs410.05 Million ≈ $4.43 Million	Rs-5.95 Million ≈ $-64.31K	-0.015x	+96.00%
2009-03-31	Rs385.23 Million ≈ $4.17 Million	Rs-139.82 Million ≈ $-1.51 Million	-0.363x	-105.51%
2008-03-31	Rs118.55 Million ≈ $1.28 Million	Rs-20.94 Million ≈ $-226.43K	-0.177x	-115.97%
2007-03-31	Rs91.39 Million ≈ $988.34K	Rs101.06 Million ≈ $1.09 Million	1.106x	+1151.53%
2006-03-31	Rs56.78 Million ≈ $614.05K	Rs-5.97 Million ≈ $-64.57K	-0.105x	+83.71%
2005-03-31	Rs42.55 Million ≈ $460.13K	Rs-27.46 Million ≈ $-297.02K	-0.646x	--

About Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic

Market Cap

$79.56 Million

Rs7.36 Billion INR

Market Cap Rank

#20200 Global

#1101 in India

Share Price

Rs311.00

Change (1 day)

+0.00%

52-Week Range

Rs99.16 - Rs312.60

All Time High

Rs507.50